Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL76427 | 1.00 | RNPEP (0.52) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL164056 | 1.00 | RNPEP (0.52) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL30975661 | 1.00 | RNPEP (0.52) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| Hydrogen Sulfide SCHEMBL1498068 | 0.98 | RNPEP (0.50) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| Hydrogen Sulfide SCHEMBL1498065 | 0.98 | RNPEP (0.50) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| Iodide SCHEMBL3658381 | 0.98 | RNPEP (0.50) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| Iodide SCHEMBL3658380 | 0.98 | RNPEP (0.50) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| Hydrochloric Acid SCHEMBL7204481 | 0.98 | RNPEP (0.50) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| Hydrogen Sulfide SCHEMBL11572294 | 0.98 | RNPEP (0.50) | RNPEPLMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL28212888 | 0.98 | RNPEP (0.50) | RNPEPLMNAALDH1A1NPSR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 883 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186634-A1 | METHODS OF TREATING SMALL CELL LUNG CANCER | Evergreen Discovery, LLC (US) | 2025-06-12 | — | — | US | claimed |
| US-20240350644-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN DER YANG (US) | 2024-10-24 | — | — | US | claimed |
| CN-118239879-A | Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine | 泰山学院 | 2024-06-25 | — | — | CN | claimed |
| CN-115671286-B | Stereocomplex for delivery of anticancer agents | 田德扬 | 2023-12-08 | — | — | CN | claimed |
| CN-117004543-A | Genetically engineered bacterium for producing methyl selenocysteine and preparation and application thereof | 北京工商大学 | 2023-11-07 | — | — | CN | claimed |
| EP-4237427-A1 | ANTIBACTERIAL CYCLOPEPTIDES TARGETING ACINETOBACTER AND OTHER GRAM-NEGATIVE PATHOGENS | University of Utah Research Foundation (US) | 2023-09-06 | — | — | EP | claimed |
| WO-2023157003-A1 | METHODS FOR SHORTENING LAG PHASE DURATION IN MICROORGANISMS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-08-24 | — | — | WO | claimed |
| WO-2023069332-A1 | CELL PERMEABLE MACROCYCLIC PEPTIDES USEFUL FOR EIF4E CAP-BINDING SITE INHIBITION | MERCK SHARP & DOHME LLC (US) | 2023-04-27 | — | — | WO | claimed |
| WO-2023044455-A2 | RNA STABILIZATION | TEAM MEDICAL LLC (US) | 2023-03-23 | — | — | WO | claimed |
| EP-4137527-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN, Der-Yang (US) | 2023-02-22 | — | — | EP | claimed |
| US-20030120032-A1 | N-methyl-homocysteines and their use as well as process for their production | SCHERING AG (DE) | 2003-06-26 | — | — | US | claimed |
| WO-2003042163-A1 | N-METHYL-HOMOCYSTINES, USE THEREOF AND METHOD FOR THE PRODUCTION THEREOF | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-05-22 | — | — | WO | claimed |
| WO-2003011047-A1 | ADDITIVE FOR USE IN FEEDING STUFF OR DRINKING WATER | BERG & SCHMIDT GMBH & CO. (DE) | 2003-02-13 | — | — | WO | claimed |
| EP-1259218-A2 | COSMETIC COMPOSITION FOR THE TREATMENT OF SKIN AGEING AND/OR STRESSED SKIN | Kuhs Kosmetik GmbH & Co. KG (DE) | 2002-11-27 | — | — | EP | claimed |
| WO-2002089770-A2 | TOPICAL LAMELLAR DOUBLE MEMBRANE STRUCTURE COMPOSITION CONTAINING N-ACYL-ETHANOLAMINE AND/OR A QUATERNARY AMMONIUM SALT AND/OR ADENOSYLMETHIONINE | KUHS GMBH & CO. KG (DE) | 2002-11-14 | — | — | WO | claimed |
| WO-2001064832-A2 | COMPOSITION FOR USE ON PLANTS | GHYCZY MIKLOS (DE) | 2001-09-07 | — | — | WO | claimed |
| WO-2001062222-A2 | COSMETIC COMPOSITION, ESPECIALLY FOR USE ON AGING AND/OR STRESSED SKIN | KUHS KOSMETIK GMBH & CO. KG (DE) | 2001-08-30 | — | — | WO | claimed |
| EP-0078152-B1 | SALTS OF SULFODEHYDROABIETIC ACID AND TREATMENT OF GASTRO-INTESTINAL DISEASES | Tanabe Seiyaku Co., Ltd. (JP) | 1986-05-07 | — | — | EP | claimed |
| EP-0030505-B1 | LACTONES SUBSTITUTED BY AN AMINO-ACID RESIDUE, THEIR PREPARATION AND THEIR USE IN THE SEPARATION OF SAID LACTONES OR AMINO ACIDS | ROUSSEL-UCLAF (FR) | 1985-07-24 | — | — | EP | claimed |
| EP-0082568-B1 | RETRO-INVERSO ANALOGUES OF C-TERMINAL PENTA AND HEXAPEPTIDES OF SUBSTANCE P. | ANIC S.p.A. (IT) | 1984-11-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030120032-A1 | N-methyl-homocysteines and their use as well as process for their production | BHMT, BHMT2, AHCY | RNPEP 481/4885LMNA 2897/4885ALDH1A1 2396/4885 |
| US-20250186634-A1 | METHODS OF TREATING SMALL CELL LUNG CANCER | SSTR2, CCKBR, GRPR | RNPEP 1238/4885LMNA 3864/4885ALDH1A1 4343/4885 |
| US-20240350644-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TOP2A, TSG101, TOP1 | RNPEP 2109/4885LMNA 2051/4885ALDH1A1 2539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.